Skip to content
Search

Latest Stories

ITH Pharma fined £1.2m after supplying contaminated baby feed

A pharmaceutical company was fined over £1 million on Friday (April 24) for supplying contaminated feed for premature babies and potentially causing "serious harm".

Nineteen infants were infected at nine hospitals in England after receiving a contaminated batch of ITH Pharma's "total parenteral nutrition".


They had all received the fluid directly into their bloodstream because they were unable to feed on their own.

Three of the babies later died, although Southwark Crown Court in south London was told the deaths were not related to the product or caused by the company.

But judge Deborah Taylor said in one death, of a premature twin boy, the company's processes risked "serious harm and/or death".

Metropolitan Police launched an investigation in 2014 after the three babies died and another 20 needed treatment when they contracted sepsis.

The force said ITH Pharma were fined £1.2 million ($1.5 million, 1.4 million euros) after pleading guilty to three offences at an earlier hearing.

The company admitted one charge of failing to make a suitable and sufficient risk assessment, and two of supplying a medicinal product "not of the nature or quality specified in the prescription".

Detective chief inspector Richard Leonard, who led the investigation, paid tribute to the families of those affected.

"We commend their bravery and dignity in coming to court and reliving their most difficult moments," he said in a statement.

"We hope they can take some comfort in the fact the criminal proceedings have now concluded."

ITH Pharma said it extended its sympathies to the families of those affected and accepted the fine imposed by the court.

A spokesman called the events in May 2014 "wholly exceptional".

"Since 2008, parenteral nutrition produced by ITH has helped many tens of thousands of the most vulnerable babies survive premature and complex births."

More For You

Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
After US and EU, UK approves Bavarian Nordic’s chikungunya vaccine

Bavarian Nordic plans to launch the vaccine in the UK in summer 2025

Getty Images

Chikungunya vaccine Vimkunya approved for use in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Vimkunya, a vaccine developed by Bavarian Nordic A/S to prevent chikungunya disease in people aged 12 years and older.

The UK approval follows earlier approvals by the U.S. Food and Drug Administration (FDA) and the European Commission in February 2025, making this the third regulatory green light for the vaccine.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
Many patients report inaccuracies or missing details in their NHS medical records

Inaccurate information can result in serious harm or even death, warns Healthwatch England.

Image Credit: Getty Images

1 in 4 adults have spotted errors in their NHS medical records, survey finds

Healthwatch England has raised the alarm over the risks posed by inaccurate medical records as research reveals widespread errors in NHS patient information.

Commissioned by Healthwatch England and conducted by BMG Research, the survey polled a representative sample of 1,800 adults in England between 24 and 27 March 2025.

Keep ReadingShow less
Lib Dems condemn rising unsolved crimes, say shoplifting and burglary ‘effectively decriminalised’

Leicestershire police recorded the lowest charge rate for shoplifting in the country.

Gettyimages

Shoplifting and burglary ‘effectively decriminalised’, warn Lib Dems as unsolved crimes soar

The Liberal Democrats have raised alarm over what they describe as the “decriminalisation” of burglary and shoplifting, as new data reveals that the vast majority of such offences across Britain are going unsolved.

Figures revealed by the House of Commons Library research, commissioned by the party, showed that only 5.25 per cent of shoplifting offences in London last year led to a suspect being charged.

Keep ReadingShow less